home / stock / ions / ions news


IONS News and Press, Ionis Pharmaceuticals Inc. From 11/02/23

Stock Information

Company Name: Ionis Pharmaceuticals Inc.
Stock Symbol: IONS
Market: NASDAQ
Website: ionispharma.com

Menu

IONS IONS Quote IONS Short IONS News IONS Articles IONS Message Board
Get IONS Alerts

News, Short Squeeze, Breakout and More Instantly...

IONS - Ionis Pharmaceuticals, Inc. (IONS) Q3 2023 Earnings Call Transcript

2023-11-02 17:20:10 ET Ionis Pharmaceuticals, Inc. (IONS) Q3 2023 Earnings Conference Call November 02, 2023 11:30 AM ET Company Participants Wade Walke - Senior Vice President, Investor Relations Brett Monia - Chief Executive Officer Onaiza Cadoret - Chief Globa...

IONS - Ionis Pharmaceuticals GAAP EPS of -$1.03 in-line, revenue of $144M beats by $7.62M

2023-11-02 07:03:11 ET More on Ionis Pharmaceuticals Ionis Pharmaceuticals: Mid-Sized Pharma Is A Strong Buy Opportunity For All-Comers Ionis Pharmaceuticals, Inc. (IONS) Q2 2023 Earnings Call Transcript Ionis Pharmaceuticals Q3 2023 Earnings Preview Biogen u...

IONS - Expected US Company Earnings on Thursday, November 2nd, 2023

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

IONS - Ionis reports third quarter 2023 financial results

Ionis reports third quarter 2023 financial results PR Newswire Olezarsen Phase 3 data showed significant triglyceride lowering, substantial reductions in acute pancreatitis attacks and favorable safety and tolerability in patients with FCS; on track for regulatory filings in e...

IONS - Expected earnings - Ionis Pharmaceuticals Inc.

Ionis Pharmaceuticals Inc. (IONS) is expected to report $-1.01 for Q3 2023

IONS - Ionis Pharmaceuticals Q3 2023 Earnings Preview

2023-11-01 12:48:49 ET More on Ionis Pharmaceuticals Ionis Pharmaceuticals: Mid-Sized Pharma Is A Strong Buy Opportunity For All-Comers Ionis Pharmaceuticals, Inc. (IONS) Q2 2023 Earnings Call Transcript Biogen updates Phase 1 data for Ionis-partnered Alzheimerȁ...

IONS - Biogen updates Phase 1 data for Ionis-partnered Alzheimer's drug

2023-10-25 12:00:42 ET More on Biogen, Ionis, etc. Biogen - Revised Revenue Forecasting To 2030 - New CEO Faces Major Challenges Biogen Inc. (BIIB) Management presents at Decentralized Clinical Trials in Focus Conference (Transcript) Biogen Inc. (BIIB) Morgan Stanley...

IONS - Ionis to hold third quarter 2023 financial results webcast

Ionis to hold third quarter 2023 financial results webcast PR Newswire Webcast scheduled for Thursday, November 2 at 11:30 a.m. Eastern Time CARLSBAD, Calif. , Oct. 19, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced toda...

IONS - ClearBridge Multi Cap Growth Strategy Q3 2023 Portfolio Manager Commentary

2023-10-16 14:50:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The ClearBridge Multi ...

IONS - ClearBridge Aggressive Growth Strategy Q3 2023 Portfolio Manager Commentary

2023-10-16 05:59:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Stock selection has be...

Previous 10 Next 10